Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-21Clinical Trial Update: Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression
This clinical trial update notes the completion of a study evaluating the usefulness of the Heidelberg Retina Tomograph for monitoring glauc…
-
FDA approval · 2014-05-19FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy [Phase 4]
Phase 4 trial results evaluate the safety and efficacy of adding AZARGA to prostaglandin therapy for glaucoma and ocular hypertension; resul…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients [Phase 4]
A Phase 4 clinical trial conducted by Aristotle University of Thessaloniki evaluated 24-hour intraocular pressure and blood pressure control…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) [Phase 3]
Phase 3 trial update for preservative-free tafluprost (MK-2452) in open-angle glaucoma or ocular hypertension completed with results posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Efficacy of Changing to TRAVATAN® From Prior Therapy [Phase 4]
Phase 4 study evaluating the efficacy of switching to TRAVATAN from prior therapy in open-angle glaucoma and ocular hypertension; results ha…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: AR-12286 in Combination With Latanoprost [Phase 2]
A Phase 2 trial evaluating AR-12286 in combination with latanoprost for glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects [Phase 1]
Phase 1 study evaluating three ophthalmic formulations in healthy subjects has been completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: 24-hour Efficacy of AR-12286 [Phase 2]
Phase 2 trial evaluating the 24-hour efficacy of AR-12286 for open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP) [Phase 2]
This update confirms the completion of a Phase 2 study evaluating AR-12286 in patients with elevated intraocular pressure. No efficacy resul…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing brinzolamide/brimonidine fixed combination given twice daily versus separate brinzolamide and brimonidine in open-an…
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Safety and Efficacy of Combigan® Ophthalmic Solution in Korea
The document reports the completion of a Korea-based trial evaluating the safety and efficacy of Combigan ophthalmic solution for open-angle…
-
FDA approval · 2014-04-03FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental NDA for LATANOPROST submitted by Mylan Pharmaceuticals Inc. The approval pertains to latanoprost, a therapy used…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
This document reports the results of an observational study evaluating Lumigan 0.01% (bimatoprost) in patients with primary open-angle glauc…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days [Phase 2]
Phase 2 trial evaluating PG286 ophthalmic solution 0.5% versus its components over 28 days in open-angle glaucoma and ocular hypertension ha…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
A Phase 3 trial compared a fixed-dose combination of brinzolamide 1% and timolol 0.5% with separate brinzolamide 1% plus timolol 0.5% in ope…
-
FDA approval · 2014-03-12FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, indicating a modification or addition to th…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
This document reports the completion of a Phase 1/Phase 2 safety and efficacy study of OPA-6566 Ophthalmic Solution in subjects with primary…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 study comparing brinzolamide/brimonidine fixed-dose combination given twice daily to its individual components in open-angle glaucom…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) [Phase 4]
A Phase 4 safety and efficacy study evaluating bimatoprost 0.01% in primary open-angle glaucoma or ocular hypertension; results were posted …
-
FDA approval · 2014-01-22FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental NDA for ALPHAGAN P (brimonidine tartrate) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG [Phase 2]
This update reports the completion of a Phase 2 study evaluating L-PPDS with adjunctive Xalatan eye drops in individuals with ocular hyperte…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Efficacy of Changing to DUOTRAV® From Prior Therapy [Phase 4]
Phase 4 trial assessing switching to DuoTrav from prior therapy in open-angle glaucoma, ocular hypertension, and pigment dispersion glaucoma…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Patient Preference Comparison of AZARGA Versus COSOPT [Phase 4]
Phase 4 trial comparing patient preference between AZARGA and COSOPT in open-angle glaucoma and ocular hypertension; results were completed …
-
CLINICAL_TRIALS research · 2013-12-12Clinical Trial Update: Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma
This item provides a clinical trial update on early diagnosis, pathogenesis, and progression of open-angle glaucoma. The study includes Prim…